source
- Some U.S. Employers Plan to End GLP-1 Obesity Drug Coverage in 2027, Even as Prices FallA Reuters report says roughly 10% of U.S. employers that currently cover GLP-1 medicines for weight loss intend to stop covering them in 2027. The move comes as enrollment in obesity-treating drugs…
- AMA and lawmakers challenge insurer AI denial practices, call for oversightThe American Medical Association and several members of Congress are publicly opposing recent denials of care that rely on artificial‑intelligence algorithms used by insurers. The Department of He…